Impel Pharmaceuticals

About:

Impel Pharmaceuticals is a pharmaceutical company that creates intranasal drug treatments for central nervous system disorders.

Website: https://impelnp.com/

Twitter/X: NosetoBrain

Top Investors: Norwest Venture Partners, Kohlberg Kravis Roberts, Silicon Valley Bank, Oaktree Capital Management, Vivo Capital

Description:

Impel Pharmaceuticals is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.